Logo do repositório

The lipodystrophy syndrome as a risk marker for cardiovascular disease in patients with HIV/AIDS treated with HAART

Página do item simplificado
dc.contributor.authorPereira, Valdelias Xavier
dc.contributor.authorDe Abreu, Luiz Carlos
dc.contributor.authorValenti, Vitor E. [UNESP]
dc.contributor.authorRaimundo, Rodrigo D.
dc.contributor.authorDa Silva, Mariliza Henrique
dc.contributor.authorOliveira, Fernando R.
dc.contributor.authorSalatini, Renata
dc.contributor.authorRoque, Adriano L.
dc.contributor.authorDe Toledo Blake, Marcia
dc.contributor.authorDias, Erick Silva
dc.contributor.authorFilho, Celso F.
dc.contributor.authorFinotti, Vivian
dc.contributor.authorFerreira, Celso
dc.contributor.institutionUniversidade de São Paulo (USP)
dc.contributor.institutionLaboratory Design and Scientific Writing, Department of Community Health, ABC Medical School
dc.contributor.institutionUniversidade Estadual Paulista (Unesp)
dc.contributor.institutionCity of São Bernardo Do Campo, Coordinator of Outpatient Medical Specialties
dc.date.accessioned2018-12-11T16:57:25Z
dc.date.available2018-12-11T16:57:25Z
dc.date.issued2015-01-01
dc.description.abstractIntroduction: The classic risk factors for cardiovascular disease in healthy individuals are well known, however, it lacks in the literature the mechanisms that predicts cardiovascular disease in the population living with HIV-AIDS treated with HAART and presenting syndrome lipodystrophy. We aimed to investigate the risk of cardiovascular disease in HIV-AIDS patients treated with HAART and lipodystrophy syndrome. Methods: A search was performed in Medline, SciELO, Lilacs and Cochrane using the intersection between the keywords: cardiovascular disease, HIV, AIDS, HAART and lipodystrophy syndrome. Results: The selected studies demonstrated that metabolic disorders such as hyperlipidemia, central adipose hypertrophy and peripheral lipoatrophy, besides the metabolic syndrome and lipodystrophy are maker clear risks of developing cardiovascular disease in these individuals. Conclusion: The metabolic alterations in HIV-AIDS treated with HAART and presenting lipodystrophy syndrome may potentiate the development of cardiovascular diseases.en
dc.description.affiliationFederal University of São Paulo-Paulista, School of Medicine, Department of Medicine
dc.description.affiliationLaboratory Design and Scientific Writing, Department of Community Health, ABC Medical School, Av Principe de Gales, 821
dc.description.affiliationCenter for the Study of Autonomic Nervous System, Speech Therapy, Department Faculty of Sciences, UNESP
dc.description.affiliationCity of São Bernardo Do Campo, Coordinator of Outpatient Medical Specialties
dc.description.affiliationUnespCenter for the Study of Autonomic Nervous System, Speech Therapy, Department Faculty of Sciences, UNESP
dc.identifierhttp://dx.doi.org/10.3823/1677
dc.identifier.citationInternational Archives of Medicine, v. 8, n. 1, 2015.
dc.identifier.doi10.3823/1677
dc.identifier.file2-s2.0-84929454503.pdf
dc.identifier.issn1755-7682
dc.identifier.scopus2-s2.0-84929454503
dc.identifier.urihttp://hdl.handle.net/11449/171849
dc.language.isoeng
dc.relation.ispartofInternational Archives of Medicine
dc.relation.ispartofsjr0,237
dc.rights.accessRightsAcesso aberto
dc.sourceScopus
dc.subjectAIDS
dc.subjectCardiovascular disease
dc.subjectHIV
dc.subjectLipodystrophy syndrome
dc.titleThe lipodystrophy syndrome as a risk marker for cardiovascular disease in patients with HIV/AIDS treated with HAARTen
dc.typeArtigo
dspace.entity.typePublication
unesp.campusUniversidade Estadual Paulista (UNESP), Faculdade de Filosofia e Ciências, Maríliapt
unesp.departmentFonoaudiologia - FFCpt

Arquivos

Pacote original

Agora exibindo 1 - 1 de 1
Imagem de Miniatura
Nome:
2-s2.0-84929454503.pdf
Tamanho:
2.93 MB
Formato:
Adobe Portable Document Format
Descrição:
Baixar

Coleções

Marília - FFC - Faculdade de Filosofia e Ciências